Liquidia wins denial of United Therapeutics' preliminary injunction blocking YUTREPIA launch

Liquidia Corp

On May 31, Judge Andrews denied UTHR's motion for a preliminary injunction to block launch of YUTREPIA for PH-ILD.
Court found UTHR failed to show obviousness challenge lacked merit and public interest did not favor an injunction.
Ruling maintains no legal impediment to FDA granting final approval of YUTREPIA for PAH and PH-ILD; trial set for June 2025.
Earlier rulings: PTAB and Federal Circuit found YUTREPIA does not infringe other UTHR patents; UTHR plans Supreme Court appeal.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.